Nonsurgical periodontal-therapy improves glycosylated hemoglobin levels in pre-diabetic patients with chronic periodontitis

doi:10.4239/wjd.v8.i5.213

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8048)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

535

WORD

364

HTML

3923

Figures (1-1)

283

Tables (1-7)

409

Sum=5514

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

927

Download

1607

Sum=2534

May 15, 2017 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Diabetes. May 15, 2017; 8(5): 213-221
Published online May 15, 2017. doi: 10.4239/wjd.v8.i5.213

Table 1 Sociodemographic characteristics of case and control group

Sociodemographic character		Case	Control	P value
Age (mean ± SD)		41.33 ± 6.63	41.93 ± 5.77	0.710
Gender (% within the group)	Male	26.7	40	0.412
Gender (% within the group)	Female	73.3	60	0.412
Socioeconomic status (% within the group)	APL	73.3	50	0.110
Socioeconomic status (% within the group)	BPL	26.7	50	0.110

APL: Above poverty line; BPL: Below poverty line.

Table 2 Baseline periodontal parameters of case and control group (mean ± SD)

Parameters	Mean ± SD	Mean ± SD	P value
	Case group	Control group
MGI	1.55 ± 0.37	1.53 ± 0.28	0.723
PI	1.05 ± 0.24	1.03 ± 0.23	0.871
CI	1.95 ± 0.45	2.11 ± 0.48	0.173
BOP (%)	60.37 ± 13.66	64.87 ± 11.61	0.175
PPD (mm)	3.27 ± 0.29	3.24 ± 0.27	0.694
Sites with PPD ≤ 3 mm (%)	60.86 ± 12.22	64.85 ± 8.24	0.143
Sites with PPD 4-6 mm (%)	37.03 ± 11.05	34.05 ± 8.06	0.238
Sites with PPD ≥ 7 mm (%)	1.75 ± 2.28	1.01 ± 1.46	0.142
CAL (mm)	2.95 ± 0.49	3.03 ± 0.59	0.567
Sites with CAL 1-2 mm (%)	40.58 ± 11.72	41.16 ± 17.16	0.879
Sites with CAL 3-4 mm (%)	42.79 ± 7.76	41.41 ± 10.77	0.573
Sites with CAL ≥ 5 mm (%)	15.81 ± 10.60	17.67 ± 13.32	0.552

MGI: Modified gingival index; PI: Plaque index; CI: Calculus index; BOP: Bleeding on probing; PPD: Probing pocket depth; CAL: Clinical attachment level.

Table 3 Baseline systemic parameters of case and control group (mean ± SD)

Parameters	Mean ± SD	Mean ± SD	P value
	Case group	Control group
FBG (mg/dL)	107.53 ± 9.44	103.17 ± 7.84	0.060
HbA1c (%)	5.96 ± 0.17	5.97 ± 0.19	0.836
TC (mg%)	206.80 ± 38.60	191.83 ± 26.15	0.084
TG (mg%)	130 ± 51.12	129.67 ± 38.98	0.977
HDL (mg%)	44 ± 9.40	43.70 ± 4.23	0.597
LDL (mg%)	135.53 ± 35.45	122.30 ± 23.33	0.093
VLDL (mg%)	25.90 ± 10.26	25.83 ± 7.85	0.970

FBG: Fasting blood glucose; HBA1c: Glycosylated hemoglobin; TC: Total cholesterol; TG: Triglycerides; HDL: High density lipoprotein; LDL: Low density lipoprotein; VLDL: Very low density lipoprotein.

Table 4 Change in periodontal parameters of case group from base line to fourth month after non surgical periodontal therapy

Parameters	Baseline	At fourth month	P value
MGI	1.55 ± 0.37	0.42 ± 0.09	0.000^a
PI	1.05 ± 0.24	0.30 ± 0.08	0.000^a
CI	1.95 ± 0.45	0.22 ± 0.11	0.000^a
BOP (%)	60.37 ± 13.66	19.98 ± 4.35	0.000^a
PPD (mm)	3.27 ± 0.29	2.70 ± 0.24	0.000^a
Sites with PPD ≤ 3 mm (%)	60.86 ± 12.22	82.75 ± 10.28	0.000^a
Sites with PPD 4-6 mm (%)	37.03 ± 11.05	16.73 ± 10.00	0.000^a
Sites with PPD ≥ 7 mm (%)	1.75 ± 0.73	0.47 ± 0.29	0.000^a
CAL(mm)	2.95 ± 0.49	2.48 ± 0.46	0.000^a
Sites with CAL 1-2 mm (%)	40.58 ± 11.72	56.17 ± 16.73	0.000
Sites with CAL 3-4 mm (%)	42.79 ± 7.76	34.80 ± 13.49	0.003^a
Sites with CAL ≥ 5 mm (%)	15.81 ± 10.60	8.65 ± 7.81	0.000^a

^aP value ≤ 0.05. MGI: Modified gingival index; PI: Plaque index; CI: Calculus index; BOP: Bleeding on probing; PPD: Probing pocket depth; CAL: Clinical attachment loss.

Table 5 Change in systemic parameters from baseline and to fourth month after non surgical periodontal therapy in case group (mean ± SD)

Parameters	Baseline	At fourth month	P value
FBG (mg/dL)	107.53 ± 9.44	103.63 ± 9.48	0.018^a
HBA1c (%)	5.96 ± 0.19	5.74 ± 0.22	0.000^a
TC (mg%)	206.80 ± 38.60	202.63 ± 41.30	0.343
TG (mg%)	130.00 ± 51.12	127.30 ± 55.52	0.598
HDL (mg%)	44.70 ± 9.40	45.87 ± 6.71	0.404
LDL (mg%)	135.53 ± 35.45	129.60 ± 33.71	0.112
VLDL (mg%)	25.90 ± 10.26	25.24 ± 11.15	0.512

^aP value ≤ 0.05. FBG: Fasting blood glucose; HBA1c: Glycosylated hemoglobin; TG: Triglycerides; TC: Total cholesterol; HDL: High density lipoprotein; LDL: Low density lipoprotein; VLDL: Very low density lipoprotein.

Table 6 Mean difference (mean ± SD) in periodontal parameters from baseline to fourth month re-evaluation for case and control group

Parameters	Mean difference in case group	Mean difference in control group	P value
MGI	1.13 ± 0.32	-0.006 ± 0.02	0.000^a
PI	0.75 ± 0.21	-0.0003 ± 0.014	0.000^a
CI	1.73 ± 0.43	-0.017 ± 0.05	0.000^a
BOP (%)	40.39 ± 13.48	-0.41 ± 0.77	0.000^a
PPD (mm)	0.56 ± 0.16	-0.01 ± 0.006	0.000^a
Sites with PD ≤ 3 mm (%)	-21.89 ± 10.10	0.08 ± 0.46	0.000^a
Sites with PD 4-6 mm (%)	20.29 ± 10.10	0.05 ± 0.54	0.000^a
Sites with PD ≥ 7 mm (%)	1.28 ± 1.75	-0.054 ± 0.20	0.000^a
CAL (mm)	0.47 ± 0.19	-0.001 ± 0.019	0.000^a
Sites with CAL 1-2 mm (%)	-15.59 ± 11.53	0.078 ± 0.42	0.000^a
Sites with CAL 3-4 mm (%)	7.99 ± 13.25	0.093 ± 0.43	0.000^a
Sites with CAL ≥ 5 mm (%)	7.16 ± 4.79	-0.13 ± 0.36	0.000^a

^aP value ≤ 0.05. MGI: Modified gingival index; PI: Plaque index; CI: Calculus index; BOP: Bleeding on probing; PPD: Probing pocket depth; CAL: Clinical attachment loss.

Table 7 Mean difference (mean ± SD) in systemic parameters from baseline to fourth month re-evaluation for case and control group

Parameters	Mean difference in case group	Mean difference in control group	P value
FBG (mg/dL)	3.90 ± 8.48	-1.66 ± 6.04	0.005^a
HBA1c (%)	0.22 ± 0.11	-0.056 ± 0.10	0.000^a
TC (mg%)	4.16 ± 23.66	-6.43 ± 16.38	0.048^a
TG (mg%)	2.70 ± 27.71	4.50 ± 27.65	0.802
HDL (mg%)	-1.16 ± 7.54	0.00 ± 3.05	0.436
LDL (mg%)	5.93 ± 19.81	-7.16 ± 16.02	0.007^a
VLDL (mg%)	0.65 ± 5.38	0.96 ± 5.50	0.824

^aP value ≤ 0.05. FBG: Fasting blood glucose; HBA1c: Glycosylated hemoglobin; TG: Triglycerides; HDL: High density lipoprotein; LDL: Low density lipoprotein; VLDL: Very low density lipoprotein; TC: Total cholesterol.

Citation: Joseph R, Sasikumar M, Mammen J, Joseraj MG, Radhakrishnan C. Nonsurgical periodontal-therapy improves glycosylated hemoglobin levels in pre-diabetic patients with chronic periodontitis. World J Diabetes 2017; 8(5): 213-221
URL: https://www.wjgnet.com/1948-9358/full/v8/i5/213.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i5.213